BLGO BioLargo

BioLargo Announces Craft Brewery Pre-Commercial Pilot Study Project Funded by Innovative Conservation Program (ICP)

BioLargo Announces Craft Brewery Pre-Commercial Pilot Study Project Funded by Innovative Conservation Program (ICP)

WESTMINSTER, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- BioLargo, Inc. (OTCQB: BLGO), an innovator of sustainable science and technology and full-service environmental engineering company, announced that the Innovative Conservation Program (ICP) () had granted funding to support a pre-commercial pilot water treatment study project at the Joshua Tree Brewery, a brewery under construction in Joshua Tree, California, slated to open in late 2018. The pilot project will feature BioLargo’s Advanced Oxidation System (AOS) and Aquacycl’s BioElectrochemical Treatment Technology (BETT™) to demonstrate that these combined technologies are capable of providing effective and cost-efficient treatment of the brewery’s wastewater to meet California discharge standards and avoid regulatory non-compliance. The project’s goal is to allow the wastewater to be used for landscaping irrigation.

Aquacycl provides microbial fuel cell technologies for packaged wastewater treatment plants that can eliminate primary sludge, recover energy as direct electricity (no methane), and enable onsite water reuse at operational costs that are 50%-80% lower than incumbent technologies and at competitive capital costs.

BioLargo’s AOS complements the Aquacycl technology by providing high fidelity disinfection and elimination of recalcitrant organic compounds and a lower cost and lower energy requirement than other “polishing step” technologies such as UV and ozone. BETT™ and AOS together stand to offer breweries and other food and beverage facilities a robust and cost-efficient option for wastewater treatment to meet regulatory discharge standards at a significant price reduction to current systems.

“BioLargo is extremely pleased to have met Aquacycl via the Maritime Alliance and join them to provide an important synergistic solution to advance the cause of water conservation and water reuse for the Food and Beverage industry. We are thankful for the continued support of innovation by the Innovative Conservation Program and for its funding partners’ commitment to drive new water technologies developed by companies like ours,” commented Dennis Calvert, CEO of BioLargo.

“Aquacycl is thrilled to be working with BioLargo, Joshua Tree Brewery to demonstrate cost-effective, modular, and scalable solutions for the treatment of brewery wastewater, and evaluate new enabling technologies for onsite reuse,” commented Orianna Bretschger, CEO, Aquacycl.

About BioLargo, Inc.

BioLargo, Inc. is an innovative technology incubator and environmental engineering company driven by a mission to “make life better” by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We incubate disruptive technologies by providing the capital, support, and expertise to expedite them from “cradle” to “maturity” (). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (). Our industrial odor control division, Odor-No-More () features CupriDyne Clean Industrial Odor Eliminator (), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water () develops the Advanced Oxidation System “AOS”, a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical () features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.

About Aquacycl, LLC.

Founded in 2016 and headquartered in San Diego, California, ™ () develops and manufactures the patented BioElectrochemical Treatment Technology (BETT™) for use in distributed wastewater treatment plants. The BETT™ systems can eliminate up to 80% of total suspended solids, recover energy as direct electricity (no methane), and enable onsite water reuse at operational costs that are 50%-95% lower than incumbent technologies. Aquacycl provides BETT™ systems through competitive equipment leasing and service plans; and strives to be the leading global provider of bioelectrochemical technologies for decentralized industrial, agricultural, military and emerging market wastewater treatment applications.

Contact Information

Dennis Calvert

President and CEO

BioLargo, Inc.

949-643-9540 x2

EN
23/08/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BioLargo

Sean Conroy
  • Sean Conroy

BioLargo - Firing on all cylinders

BioLargo reported $666,000 in total Q320 sales (+24.7% y-o-y), a new record, a $1.9m operating loss (flat year-on-year) and a $2.39m net loss (from $3.89m in Q319). It had $356,000 in Q320 sales from ONM Environmental, down 10% from Q319, but the division recovered significantly since the start of the pandemic (up 19% from Q120). Sequentially, companywide revenue growth was up 56% over Q220, a strong bounce back from COVID-19 disruptions, and total sales are up 15% for 9M20 to $1.52m. BioLargo a...

Sean Conroy
  • Sean Conroy

BioLargo - Clyraguard to be a major growth driver

BioLargo stated that it expects Clyra Medical (of which it owns a 48% interest) and its Clyraguard product to be a major driver of growth in the coming periods. Clyra Medical signed an agreement with a major national distributor in July, with the first substantial sales to occur in Q320. Clyra Medical reported a small revenue ($21,000) for Q220, reflecting one week of sales from a previous test marketing run.

 PRESS RELEASE

Dennis P. Calvert, President & CEO of BioLargo, Inc. Provides Key Upda...

Dennis P. Calvert, President & CEO of BioLargo, Inc. Provides Key Updates and Outlook in a New Audio Interview with SmallCapVoice.com AUSTIN, Texas, June 08, 2020 (GLOBE NEWSWIRE) -- SmallCapVoice.com, Inc. (SCV) and BioLargo, Inc. (OTCQB:BLGO)(“the Company”), developer of sustainable technologies and a full-service environmental engineering company, today announced that a new audio interview with the Company is now available. The interview featuring an overview of BLGO’s current news and moves can be heard at . Dennis P. Calvert, President & CEO of BioLargo, discussed the Company’s bu...

Sean Conroy
  • Sean Conroy

BioLargo - Clyra launches Clyraguard

Clyra Medical, BioLargo’s partially owned (36%) subsidiary, recently announced that it registered with the FDA and launched Clyraguard, a disinfectant marketed for the treatment of non-critical surfaces such as personal protective equipment (PPE) that is non-irritating to skin. Concurrent with this BioLargo announced the results of two studies that showed Clyraguard and the company’s environmental product CupriDyne could both fully inactivate COVID-19.

Sean Conroy
  • Sean Conroy

BioLargo - A record-setting year

BioLargo reported record revenue of $1.86m for 2019, a 36% increase over 2018 and a record single quarter revenue of over $560,000 for Q4. Odor-no-More (ONM) had its best year to date with $1.46m in revenue ($832,000 gross profit). However, ONM fell short of its goal of breaking even for the year with a loss of $337,000 (albeit improved from the 2018 $433,000 loss) due to increased headcount for future growth. The company noted that in 2020 it will focus on increasing sales through improved dist...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch